Circulating Osteogenic Progenitor Cells in Mild, Moderate, and Severe Aortic Valve Stenosis

Mohammed Al-Hijji, Nupoor Narula, Jason L. Go, Sundeep Khosla, Maurice E Sarano, Darrell Loeffler, Ryan Lennon, Lilach O Lerman, Amir Lerman

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The aim of this study was to characterize endothelial progenitor cells with osteoblastic phenotype (EPC-OCNs) and their role in individuals with varying degrees of aortic stenosis (AS). Peripheral blood mononuclear cells retrieved from blood samples of individuals with mild (n=40), moderate (n=35), or severe (n=103) AS from September 16, 2008, through March 30, 2015, were analyzed by flow cytometry for the EPC surface markers CD34, CD133, and kinase insert domain receptor (KDR) and the osteoblastic cell surface marker OCN. Levels of EPC-OCNs were correlated with AS severity and calcifications. Patients with severe AS had significantly elevated numbers of total circulating EPC-OCNs, including the EPC-OCN subtypes CD133 + /OCN + , CD34 + /CD133 + /OCN + , and CD133 + /KDR + /OCN + , compared with those with mild AS. Individuals with moderate AS also had significantly increased numbers of the circulating progenitor cell CD133 + /OCN + compared with patients with mild AS. There was a significant association between total circulating EPC-OCN levels and aortic valve (AV) calcification, AV mean gradient, and AV area measured by echocardiography. In summary, this study found the presence of circulating EPC-OCNs in patients with progressive AV stenosis. These findings might support the potential role for EPC-OCNs in the progression of AV stenosis and calcification.

Original languageEnglish (US)
Pages (from-to)652-659
Number of pages8
JournalMayo Clinic proceedings
Volume94
Issue number4
DOIs
StatePublished - Apr 1 2019

Fingerprint

Aortic Valve Stenosis
Stem Cells
Phenotype
Vascular Endothelial Growth Factor Receptor-2
Aortic Valve
Endothelial Progenitor Cells
Echocardiography
Blood Cells
Flow Cytometry

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Circulating Osteogenic Progenitor Cells in Mild, Moderate, and Severe Aortic Valve Stenosis. / Al-Hijji, Mohammed; Narula, Nupoor; Go, Jason L.; Khosla, Sundeep; Sarano, Maurice E; Loeffler, Darrell; Lennon, Ryan; Lerman, Lilach O; Lerman, Amir.

In: Mayo Clinic proceedings, Vol. 94, No. 4, 01.04.2019, p. 652-659.

Research output: Contribution to journalArticle

Al-Hijji, Mohammed ; Narula, Nupoor ; Go, Jason L. ; Khosla, Sundeep ; Sarano, Maurice E ; Loeffler, Darrell ; Lennon, Ryan ; Lerman, Lilach O ; Lerman, Amir. / Circulating Osteogenic Progenitor Cells in Mild, Moderate, and Severe Aortic Valve Stenosis. In: Mayo Clinic proceedings. 2019 ; Vol. 94, No. 4. pp. 652-659.
@article{c01561b727a24db0b0f9337ea1465253,
title = "Circulating Osteogenic Progenitor Cells in Mild, Moderate, and Severe Aortic Valve Stenosis",
abstract = "The aim of this study was to characterize endothelial progenitor cells with osteoblastic phenotype (EPC-OCNs) and their role in individuals with varying degrees of aortic stenosis (AS). Peripheral blood mononuclear cells retrieved from blood samples of individuals with mild (n=40), moderate (n=35), or severe (n=103) AS from September 16, 2008, through March 30, 2015, were analyzed by flow cytometry for the EPC surface markers CD34, CD133, and kinase insert domain receptor (KDR) and the osteoblastic cell surface marker OCN. Levels of EPC-OCNs were correlated with AS severity and calcifications. Patients with severe AS had significantly elevated numbers of total circulating EPC-OCNs, including the EPC-OCN subtypes CD133 + /OCN + , CD34 + /CD133 + /OCN + , and CD133 + /KDR + /OCN + , compared with those with mild AS. Individuals with moderate AS also had significantly increased numbers of the circulating progenitor cell CD133 + /OCN + compared with patients with mild AS. There was a significant association between total circulating EPC-OCN levels and aortic valve (AV) calcification, AV mean gradient, and AV area measured by echocardiography. In summary, this study found the presence of circulating EPC-OCNs in patients with progressive AV stenosis. These findings might support the potential role for EPC-OCNs in the progression of AV stenosis and calcification.",
author = "Mohammed Al-Hijji and Nupoor Narula and Go, {Jason L.} and Sundeep Khosla and Sarano, {Maurice E} and Darrell Loeffler and Ryan Lennon and Lerman, {Lilach O} and Amir Lerman",
year = "2019",
month = "4",
day = "1",
doi = "10.1016/j.mayocp.2019.01.005",
language = "English (US)",
volume = "94",
pages = "652--659",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "4",

}

TY - JOUR

T1 - Circulating Osteogenic Progenitor Cells in Mild, Moderate, and Severe Aortic Valve Stenosis

AU - Al-Hijji, Mohammed

AU - Narula, Nupoor

AU - Go, Jason L.

AU - Khosla, Sundeep

AU - Sarano, Maurice E

AU - Loeffler, Darrell

AU - Lennon, Ryan

AU - Lerman, Lilach O

AU - Lerman, Amir

PY - 2019/4/1

Y1 - 2019/4/1

N2 - The aim of this study was to characterize endothelial progenitor cells with osteoblastic phenotype (EPC-OCNs) and their role in individuals with varying degrees of aortic stenosis (AS). Peripheral blood mononuclear cells retrieved from blood samples of individuals with mild (n=40), moderate (n=35), or severe (n=103) AS from September 16, 2008, through March 30, 2015, were analyzed by flow cytometry for the EPC surface markers CD34, CD133, and kinase insert domain receptor (KDR) and the osteoblastic cell surface marker OCN. Levels of EPC-OCNs were correlated with AS severity and calcifications. Patients with severe AS had significantly elevated numbers of total circulating EPC-OCNs, including the EPC-OCN subtypes CD133 + /OCN + , CD34 + /CD133 + /OCN + , and CD133 + /KDR + /OCN + , compared with those with mild AS. Individuals with moderate AS also had significantly increased numbers of the circulating progenitor cell CD133 + /OCN + compared with patients with mild AS. There was a significant association between total circulating EPC-OCN levels and aortic valve (AV) calcification, AV mean gradient, and AV area measured by echocardiography. In summary, this study found the presence of circulating EPC-OCNs in patients with progressive AV stenosis. These findings might support the potential role for EPC-OCNs in the progression of AV stenosis and calcification.

AB - The aim of this study was to characterize endothelial progenitor cells with osteoblastic phenotype (EPC-OCNs) and their role in individuals with varying degrees of aortic stenosis (AS). Peripheral blood mononuclear cells retrieved from blood samples of individuals with mild (n=40), moderate (n=35), or severe (n=103) AS from September 16, 2008, through March 30, 2015, were analyzed by flow cytometry for the EPC surface markers CD34, CD133, and kinase insert domain receptor (KDR) and the osteoblastic cell surface marker OCN. Levels of EPC-OCNs were correlated with AS severity and calcifications. Patients with severe AS had significantly elevated numbers of total circulating EPC-OCNs, including the EPC-OCN subtypes CD133 + /OCN + , CD34 + /CD133 + /OCN + , and CD133 + /KDR + /OCN + , compared with those with mild AS. Individuals with moderate AS also had significantly increased numbers of the circulating progenitor cell CD133 + /OCN + compared with patients with mild AS. There was a significant association between total circulating EPC-OCN levels and aortic valve (AV) calcification, AV mean gradient, and AV area measured by echocardiography. In summary, this study found the presence of circulating EPC-OCNs in patients with progressive AV stenosis. These findings might support the potential role for EPC-OCNs in the progression of AV stenosis and calcification.

UR - http://www.scopus.com/inward/record.url?scp=85063412836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063412836&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2019.01.005

DO - 10.1016/j.mayocp.2019.01.005

M3 - Article

VL - 94

SP - 652

EP - 659

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 4

ER -